Stay updated on Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page.

Latest updates to the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no changes to study details, endpoints, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a new Locations section listing Connecticut and Indiana. Removed HHS Vulnerability Disclosure link and updated the page revision to v3.3.3.SummaryDifference0.3%

- Check54 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed from the page.SummaryDifference0.0%

- Check62 days agoChange DetectedRemoved the government funding/operational-status notice from the page. The study details and contact information remain available.SummaryDifference0.3%

- Check76 days agoChange DetectedThe screenshots show only minor UI/formatting adjustments with no changes to core study data such as eligibility criteria, interventions, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check105 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference4%

Stay in the know with updates to Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page.